US Patent Issued to Allarity Therapeutics Europe on June 30 for "Methods for predicting drug responsiveness in cancer patients" (Arizona Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,845, issued on June 30, was assigned to Allarity Therapeutics Europe ApS (Horsholm, Denmark).

"Methods for predicting drug responsiveness in cancer patients" was invented by Steen Knudsen (Scottsdale, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention features methods, devices, and kits for detecting gene expression in a patient with a cancer or determining responsive of a patient with a cancer to a treatment, such as treatment with 2X-121 or a pharmaceutically acceptable salt thereof. The invention further includes methods of treating a patient with a cancer by administering a treatment, e.g., treatment with 2X-121 or a phar...